Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Zejula“
Suchtreffer
Begriffe & Kennungen
Zejula · 4.8 · In NOVA, approximately 30% of patients experienced neutropenia of any grade, and 20% of patients experienced G
Eintrag öffnenZejula · 4.8 · In NOVA, approximately 50% of patients experienced anaemia of any grade, and 25% experienced Grade 3/4 anaemia
Eintrag öffnenZejula · 4.8 · In NOVA, approximately 50% of patients experienced anaemia of any grade, and 25% experienced Grade 3/4 anaemia
Eintrag öffnenZejula · 4.8 · In NOVA, approximately 60% of patients experienced thrombocytopenia of any grade, and 34% of patients experien
Eintrag öffnenZejula · 4.8 · In NOVA, approximately 60% of patients experienced thrombocytopenia of any grade, and 34% of patients experien
Eintrag öffnenZejula · 4.8 · In NOVA, hypertension of any grade occurred in 19.3% of patients treated with Zejula. Grade 3/4 hypertension o
Eintrag öffnenZejula · 4.8 · In NOVA, hypertension of any grade occurred in 19.3% of patients treated with Zejula. Grade 3/4 hypertension o
Eintrag öffnenZejula · 4.8 · In NOVA, in patients with relapsed ovarian cancer who had received at least two prior lines of platinum chemot
Eintrag öffnenZejula · 4.8 · In NOVA, in patients with relapsed ovarian cancer who had received at least two prior lines of platinum chemot
Eintrag öffnenZejula · 4.8 · In PRIMA, patients who were administered a starting dose of Zejula based on baseline weight or platelet count,
Eintrag öffnenZejula · 4.8 · In PRIMA, patients who were administered a starting dose of Zejula based on baseline weight or platelet count,
Eintrag öffnenZejula · 4.8 · In PRIMA, the incidence of MDS/AML was 2.3% in patients receiving Zejula and 1.6% in patients receiving placeb
Eintrag öffnenZejula · 4.8 · In PRIMA, the incidence of MDS/AML was 2.3% in patients receiving Zejula and 1.6% in patients receiving placeb
Eintrag öffnenZejula · 4.8 · Myelodysplastic syndrome/Acute myeloid leukaemia In clinical studies, MDS/AML occurred in 1% patients treated
Eintrag öffnenZejula · 4.8 · Neutropenia In PRIMA, 21% of Zejula-treated patients experienced Grade 3/4 neutropenia compared to 1% of
Eintrag öffnenZejula · 4.8 · Neutropenia In PRIMA, 21% of Zejula-treated patients experienced Grade 3/4 neutropenia compared to 1% of place
Eintrag öffnenZejula · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenZejula · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenZejula · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenZejula · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnen